Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EBIT Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 93.14298.54-62.910.46-30.07

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is 93.14 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202493.14
Mar2023298.54
Mar2022-62.91
Mar20210.46
Mar2020-30.07

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2024 93.14
-68.80
Mar2023 298.54
Positive
Mar2022 -62.91
Negative
Mar2021 0.46
Positive
Mar2020 -30.07 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹22,926.6 Cr 13.5% 6.7% 54.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,697.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹157,449.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹117,778.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,871.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹97,046.2 Cr 3.2% -1% 27.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

13.5%

6.7%

54.6%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses